YES1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.955000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.840000E-01
Normal-vs-Stage2
4.124800E-01
Normal-vs-Stage3
6.670800E-01
Normal-vs-Stage4
2.758600E-01
Stage1-vs-Stage2
4.327600E-01
Stage1-vs-Stage3
8.810200E-01
Stage1-vs-Stage4
2.980400E-01
Stage2-vs-Stage3
6.323800E-01
Stage2-vs-Stage4
4.661400E-01
Stage3-vs-Stage4
4.153400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.161600E-01
Normal-vs-AfricanAmerican
2.996800E-01
Normal-vs-Asian
5.634600E-01
Caucasian-vs-AfricanAmerican
4.415000E-01
Caucasian-vs-Asian
9.219400E-01
AfricanAmerican-vs-Asian
4.930600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.093200E-01
Normal-vs-Female
4.713200E-01
Male-vs-Female
8.375200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.117800E-01
Normal-vs-Age(41-60Yrs)
2.508400E-01
Normal-vs-Age(61-80Yrs)
6.348200E-01
Normal-vs-Age(81-100Yrs)
9.451800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.619600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.020000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.056800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.824900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.814000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.277200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.435600E-01
Normal-vs-Daily Drinker
8.308600E-01
Normal-vs-Weekly Drinker
5.819600E-01
Normal-vs-Occasional Drinker
3.733400E-01
Normal-vs-Social Drinker
3.594400E-01
Non Drinker-vs-Daily Drinker
8.738300E-02
Non Drinker-vs-Weekly Drinker
7.998800E-01
Non Drinker-vs-Occasional Drinker
3.214400E-01
Non Drinker-vs-Social Drinker
4.233200E-01
Daily Drinker-vs-Weekly Drinker
1.433810E-01
Daily Drinker-vs-Occasional Drinker
2.672200E-02
Daily Drinker-vs-Social Drinker
3.543600E-02
Weekly Drinker-vs-Occasional Drinker
6.091400E-01
Weekly Drinker-vs-Social Drinker
7.082600E-01
Occasional Drinker-vs-Social Drinker
8.720200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.450600E-01
Normal-vs-Grade 2
5.411700E-02
Normal-vs-Grade 3
5.329600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.373530E-02
Grade 1-vs-Grade 3
9.781100E-03
Grade 1-vs-Grade 4
2.450600E-01
Grade 2-vs-Grade 3
5.246400E-01
Grade 2-vs-Grade 4
5.411700E-02
Grade 3-vs-Grade 4
5.329600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.378800E-01
Normal-vs-NonDiabetic
5.022600E-01
Diabetic-vs-NonDiabetic
4.769200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.761800E-01
Normal-vs-NoPancreatitis
5.612800E-01
Pancreatitis-vs-NoPancreatitis
9.157600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.953000E-01
Normal-vs-N1
4.294800E-01
N0-vs-N1
4.862400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.783410E-01
Normal-vs-TP53-NonMutant
6.393000E-01
TP53-Mutant-vs-TP53-NonMutant
5.343100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
